.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The rational design of artificial metalloenzymes has emerged as a significant research hotspot in the field of biocatalysis. By combining abiotic metal cofactors with natural protein scaffolds, scientists can expand the functional boundaries of nature. Neuroglobin (Ngb), a member of the globin family, serves as an exceptional template for these innovations. It possesses a highly stable structure and a unique, tunable intramolecular disulfide bond (Cys46-Cys55). Consequently, researchers use Ngb to create versatile biocatalysts that outperform traditional natural enzymes in specific industrial and medical settings.
To create these hybrid catalysts, engineers employ several sophisticated strategies. Specifically, they optimize the microenvironment within the heme center and substitute key amino acid residues to alter catalytic behavior. Additionally, constructing extra intramolecular disulfide bonds enhances the protein's thermal and chemical stability. Introducing alternative metal cofactors, such as Cobalt-porphyrin, allows artificial metalloenzymes to perform non-natural reactions. These modifications successfully transform Ngb into a platform for nitrite reductase, monooxygenase, and carbene transferase activities. Furthermore, these advances deepen our structural understanding of heme-based enzymes.
The applications of Ngb-based artificial metalloenzymes extend far beyond the laboratory. In the realm of biomedicine, these enzymes show great promise for carbon monoxide (CO) detoxification. Therefore, they could lead to new emergency treatments for CO poisoning. Moreover, they play vital roles in green synthesis by reducing the environmental impact of chemical production. Environmental remediation efforts also benefit from their ability to degrade pollutants efficiently. As researchers continue to refine these scaffolds, we expect them to integrate seamlessly into diverse areas such as drug delivery and metabolic engineering.
They are hybrid catalysts formed by incorporating a synthetic, abiotic metal complex into a natural protein scaffold to achieve new-to-nature chemical reactions.
Neuroglobin is preferred due to its stable protein structure and its unique Cys46-Cys55 disulfide bond, which allows for precise tuning of the enzyme's internal environment.
Yes, potential medical uses include carbon monoxide detoxification and the activation of prodrugs within specific cellular compartments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers are leveraging neuroglobin's stable structure to design artificial metalloenzymes for applications in detoxification and green synthesis....
8 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
